Beyond Basic Beta Channel How a Popular Biotech ETF Fits Into the Coronavirus Investing Landscape By Tom LydonMay 4, 2020
Beyond Basic Beta Channel Biotech ETFs Brush Off Political Attacks on Drug Prices By Tom LydonJanuary 21, 2020
ETF of the Week ETF of the Week: Virtus LifeSci Biotech Clinical Trials ETF (BBC) By Aaron NeuwirthDecember 12, 2019
Beyond Basic Beta Channel Biotech ETFs Could Use Some Mergers & Acquisitions By Tom LydonMay 17, 2019
Leveraged & Inverse Channel Big Biopharma Mergers Could Fuel These ETFs in 2019 By Ben HernandezJanuary 10, 2019
ETF of the Week ETF of the Week: Virtus LifeSci Biotech Clinical Trials ETF (BBC) By Brenton GarenSeptember 17, 2018